Literature DB >> 8823839

The treatment of septicemia in pacemaker patients.

A Böhm1, F Bányai, I Préda, K Zámolyi.   

Abstract

The authors analyzed the data of seven patients who had undergone open heart surgery because of pacemaker endocarditis in the past 4 years. Repeated surgical interventions on the pacemaker system were found to be the most common predisposing factors. Staphylococcus aureus and Staphylococcus epidermidis were the most common causative organisms. Two-dimensional echocardiography was important in the diagnosis of cases with atypical clinical picture and negative blood cultures. We concluded that: (1) any pacemaker patient with fever should be considered to have a pacemaker endocarditis; (2) all of these patients should be examined by two-dimensional echocardiography; and (3) the total removal of the infected hardware seems to be the only way to achieve complete recovery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823839     DOI: 10.1111/j.1540-8159.1996.tb03420.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

Review 1.  Pacemaker lead complications: when is extraction appropriate and what can we learn from published data?

Authors:  F A Bracke; A Meijer; L M van Gelder
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

Review 2.  Endovascular extraction techniques: Part 2: Complications and indications.

Authors:  F A Bracke; A Meijer; B van Gelder
Journal:  Neth Heart J       Date:  2001-05       Impact factor: 2.380

Review 3.  Aspergillus fumigatus pacemaker lead endocarditis: a case report and review of the literature.

Authors:  R Leong; Brian R Gannon; Tim J Childs; Phillip A Isotalo; Hoshiar Abdollah
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

Review 4.  Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.

Authors:  M Cobo; A Ramos; J Toquero; E Muñez; T Alvárez-Espejo; M Muñoz; I Fernández
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.